Table 3 Laboratory data of cases of eosinophilic abscesses and malignant nodules
Characteristics | Eosinophilic abscess group (n = 33) | Malignant nodule group (n = 5) | P-value |
|---|---|---|---|
Blood eosinophils, number/ul | 1,808.6 ± 1,625.8 | 4,186 ± 4,053.7 | 0.160 |
Blood eosinophils, % | 20.0 ± 11.2 | 31.6 ± 21.0 | 0.243 |
Severity of eosinophilia, | 0.060 | ||
Mild (450–1,500/ul) | 52 (17/33) | 40 (2/5) | |
Moderate (1,500–5,000/ul) | 45 (15/33) | 20 (1/5) | |
Severe (5,000–/ul) | 3 (1/33) | 40 (2/5) | |
Duration of eosinophilia, months | 10.5 ± 9.8 | ||
Log total IgE | 7.4 ± 1.4 | 4.9 ± 1.2 | 0.021 |
AST, IU/l | 26.6 ± 12.9 | 112.60 ± 100.0 | 0.002 |
ALT, IU/l | 22.7 ± 18.7 | 80.0 ± 47.4 | 0.002 |
Alkaline phosphatase, IU/l | 76.4 ± 23.1 | 460.0 ± 509.8 | 0.019 |
Bilirubin, total, mg/dl | 0.9 ± 0.4 | 5.2 ± 8.3 | 0.002 |
C-reactive protein, mg/dl | 0.8 ± 0.9 | 10.8 ± 12.8 | 0.004 |
Erythrocyte sedimentation rate, mm/h | 31.3 ± 19.1 | 102.5 ± 24.8 | 0.040 |